RAFAEL HOLDINGS, INC. Unrealized Gain (Loss) on Investments
RAFAEL HOLDINGS, INC. (RFL) reported Unrealized Gain (Loss) on Investments of -$1.39 million for the 3-month period ending 2025-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. unrealized gain (loss) on investments for the quarter ending 2025-04-30 was -$1.39M.
- RAFAEL HOLDINGS, INC. unrealized gain (loss) on investments for the quarter ending 2025-01-31 was $614.00K, a 93.68% decline year-over-year.
- RAFAEL HOLDINGS, INC. unrealized gain (loss) on investments for the quarter ending 2024-10-31 was -$4.37M.
- RAFAEL HOLDINGS, INC. unrealized gain (loss) on investments for the quarter ending 2024-07-31 was $181.00K.
- RAFAEL HOLDINGS, INC. unrealized gain (loss) on investments for fiscal 2024 was $63.00K, a 90.91% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. unrealized gain (loss) on investments for fiscal 2023 was $33.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 6 month as first filed | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|
| 2025-04-30 | -$1.39M 10-Q · filed 2026-06-11 | -$779.00K derived: sum of 2 quarters · filed 2026-06-11 | -$5.14M 10-Q · filed 2026-06-11 | -$4.96M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-01-31 | $614.00K 10-Q · filed 2026-03-16 | -$3.75M 10-Q · filed 2026-03-16 | -$3.57M derived: sum of 3 quarters · filed 2026-03-16 | -$3.57M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-10-31 | -$4.37M 10-Q · filed 2025-12-12 | -$4.18M derived: sum of 2 quarters · filed 2025-12-12 | -$4.19M derived: sum of 3 quarters · filed 2025-12-12 | $5.53M derived: sum of 4 quarters · filed 2025-12-12 | |
| 2024-07-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $178.00K derived: sum of 2 quarters · filed 2025-10-29 | $9.90M derived: sum of 3 quarters · filed 2025-10-29 | $63.00K 10-K · filed 2025-10-29 | |
| 2024-04-30 | -$3.00K 10-Q · filed 2024-06-14 | $9.71M derived: sum of 2 quarters · filed 2024-06-14 | -$118.00K 10-Q · filed 2025-06-11 | $9.58M derived: sum of 4 quarters · filed 2024-12-20 | |
| 2024-01-31 | $9.72M 10-Q · filed 2024-03-14 | -$46.00K 10-Q · filed 2025-03-14 | $7.59M 10-Q · filed 2024-03-14 | $9.59M derived: sum of 3 quarters · filed 2024-12-20 | $9.45M derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-10-31 | -$46.00K 10-Q · filed 2024-12-11 | -$133.00K derived: sum of 2 quarters · filed 2024-12-20 | -$264.00K derived: sum of 3 quarters · filed 2024-12-20 | ||
| 2023-07-31 | -$87.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$218.00K derived: sum of 2 quarters · filed 2024-12-20 | $33.00K 10-K/A · filed 2024-12-20 | ||
| 2023-04-30 | -$131.00K 10-Q · filed 2024-06-14 | $120.00K 10-Q · filed 2024-06-14 | |||
| 2018-10-31 | $333.00K 10-Q · filed 2018-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |